Table 2

Pre-/Post IV Treatment Data – 39 Patients Percent Predicted, Pre- and Post- infusion with % improvement

FVC (L)

FEV 1 (L)

PEF (L/S)

FEF 25–75 (L/S)

FEF 75–85 (L/S)


Sex

Age

% Predicted

% Predicted

% Predicted

% Predicted

% Predicted


Patient

Pre

Post

%

Pre

Post

%

Pre

Post

%

Pre

Post

%

Pre

Post

%


A, L.

M

55

36

72

100%

36

79

119%

64

92

44%

35

129

269%

32

112

250%

A, S.

F

48

28

50

79%

30

48

60%

40

78

95%

30

40

33%

40

38

-5%

B, M.

F

57

69

100

45%

48

81

69%

45

115

156%

24

39

63%

30

32

7%

B, R.

M

46

73

93

27%

69

87

26%

95

106

12%

57

70

23%

66

67

2%

B, V.

F

39

34

67

97%

34

72

112%

51

59

16%

38

96

153%

26

98

277%

B, V.

F

70

38

54

42%

32

47

47%

32

53

66%

18

30

67%

25

34

36%

C, D.

M

59

27

30

11%

14

17

21%

10

12

20%

10

10

0%

32

28

-13%

C, A.

F

33

90

91

1%

80

98

23%

115

142

23%

60

108

80%

65

116

78%

C, K.

F

35

45

62

38%

34

52

53%

32

56

75%

22

36

64%

32

41

28%

D, C.

F

33

65

65

0%

49

56

14%

62

65

5%

31

41

32%

42

51

21%

D, B.

M

49

65

80

23%

72

83

15%

68

88

29%

75

80

7%

146

147

1%

D, K.

F

48

61

74

21%

56

70

25%

89

95

7%

39

60

54%

29

33

14%

F, L.

M

58

26

29

12%

12

13

8%

7

8

14%

7.4

8.1

9%

22

26

18%

G, W.

M

74

48

67

40%

25

57

128%

16

88

450%

11

37

236%

38

63

66%

G, B.

M

45

83

113

36%

83

101

22%

94

149

59%

81

70

-14%

89

60

-33%

G, G.

F

42

83

93

12%

46

82

78%

24

59

146%

31

66

113%

55

79

44%

G, L.

F

63

50

78

56%

36

60

67%

52

71

37%

17

29

71%

21

29

38%

J, E.

F

63

47

85

81%

38

84

121%

43

64

49%

19

79

316%

20

55

175%

K, H.

F

49

58

72

24%

59

72

22%

82

99

21%

53

62

17%

76

86

13%

M, A.

F

46

85

97

14%

79

89

13%

61

86

41%

71

71

0%

73

68

-7%

M, W.

M

85

74

77

4%

69

90

30%

46

82

78%

50

119

138%

148

458

209%

M, C.

F

36

93

85

-9%

52

53

2%

30

46

53%

26

25

-4%

26

25.5

-2%

M, J.

M

64

74

75

1%

49

57

16%

47

60

28%

25

37

48%

57

83

46%

O, M

F

49

90

99

10%

98

114

16%

88

167

90%

114

168

47%

145

214

48%

P, O.

F

47

54

72

33%

52

76

46%

85

84

-1%

46

82

78%

40

74

85%

R, B.

F

69

21

23

10%

16

19

19%

13

17

31%

10

11

10%

21

22

5%

S, M.

F

60

56

94

68%

45

88

96%

60

104

73%

26

66

154%

26

51

96%

S, J.

M

54

98

166

69%

76

96

26%

77

70

-9%

34

39

15%

70

90

29%

S, S.

M

40

73

85

16%

58

69

19%

68

85

25%

36

40

11%

43

38

-12%

S, D.

F

64

40

56

40%

25

33

32%

18

21

17%

15

14

-7%

42

34

-19%

S, W.

M

44

71

80

13%

52

65

25%

42

60

43%

31

40

29%

31

38

23%

T, P.

F

45

41

59

44%

26

46

77%

22

73

232%

17

27

59%

26

32

23%

W, P.

F

65

48

76

58%

17

31

82%

9

21

133%

9

11

22%

20

19

-3%

W, B.

M

38

54

72

33%

42

58

38%

32

46

44%

25

37

48%

37

50

35%

W, R.

M

40

77

77

0%

34

41

21%

27

33

22%

12

16

33%

21

24

14%

W, C.

F

55

28

39

39%

20

28

40%

17

26

53%

12

16

33%

20

23

15%

W, G.

F

70

101

108

7%

78

98

26%

34

82

141%

51

65

27%

49

62

27%

Z, A.

F

43

62

75

21%

64

75

17%

107

87

-19%

68

88

29%

57

49

-14%

Average:

52

60

76

28%

48

65

38%

50

72

44%

35

54

54%

48

70

44%

Average Overall Improvement

45%


Results were measured as percentage improvement of the percentage predicted on the Knudsen scale

Shrader Nutrition Journal 2004 3:6   doi:10.1186/1475-2891-3-6

Open Data